TAKE ACTION: The M&A Class Action Firm Launches Legal
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and...
Stay updated with breaking news from Alpn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and...
See the latest Alpine Immune Sciences Inc stock price (ALPN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) traded down 5.6% on Wednesday . The company traded as low as $36.80 and last traded at $37.02. 583,722 shares were traded during trading, a decline of 48% from the average session volume of 1,126,938 shares. The stock had previously closed at $39.21. Analyst […]
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have covered the stock in the […]
Wolfe Research started coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage issued an outperform rating and a $44.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Royal Bank of Canada lifted their target […]